WO2001029224A3 - Homologue zgpa1 de peptide de granulocyte - Google Patents
Homologue zgpa1 de peptide de granulocyte Download PDFInfo
- Publication number
- WO2001029224A3 WO2001029224A3 PCT/US2000/029177 US0029177W WO0129224A3 WO 2001029224 A3 WO2001029224 A3 WO 2001029224A3 US 0029177 W US0029177 W US 0029177W WO 0129224 A3 WO0129224 A3 WO 0129224A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polypeptides
- zgpa1
- peptide homolog
- seq
- granulocyte peptide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU15744/01A AU1574401A (en) | 1999-10-20 | 2000-10-20 | Granulocyte peptide homolog zgpa1 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16071299P | 1999-10-20 | 1999-10-20 | |
US60/160,712 | 1999-10-20 | ||
US21807000P | 2000-07-12 | 2000-07-12 | |
US60/218,070 | 2000-07-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001029224A2 WO2001029224A2 (fr) | 2001-04-26 |
WO2001029224A3 true WO2001029224A3 (fr) | 2002-02-07 |
Family
ID=26857154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/029177 WO2001029224A2 (fr) | 1999-10-20 | 2000-10-20 | Homologue zgpa1 de peptide de granulocyte |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU1574401A (fr) |
WO (1) | WO2001029224A2 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8980273B1 (en) | 2014-07-15 | 2015-03-17 | Kymab Limited | Method of treating atopic dermatitis or asthma using antibody to IL4RA |
US8986691B1 (en) | 2014-07-15 | 2015-03-24 | Kymab Limited | Method of treating atopic dermatitis or asthma using antibody to IL4RA |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2008247382B2 (en) | 2007-05-07 | 2014-06-05 | Medimmune, Llc | Anti-ICOS antibodies and their use in treatment of oncology, transplantation and autoimmune disease |
BRPI0822099A2 (pt) | 2007-12-21 | 2017-05-23 | Medimmune Ltd | membro de ligação isolado, uso de um membro de ligação isolado, método parav tratar um distúrbio, molécula de ácido nucléico isolada, célula hospedeira, e, método para produzir um membro de ligação |
WO2009100309A2 (fr) | 2008-02-08 | 2009-08-13 | Medimmune, Llc | Anticorps anti-ifnar1 ayant une affinité réduite pour le ligand fc |
WO2012019061A2 (fr) | 2010-08-05 | 2012-02-09 | Stem Centrx, Inc. | Nouveaux effecteurs et leurs procédés d'utilisation |
CA2820885A1 (fr) | 2010-12-08 | 2012-09-07 | Stem Centrx, Inc. | Nouveaux modulateurs et methodes d'utilisation |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997029765A1 (fr) * | 1996-02-16 | 1997-08-21 | The Regents Of The University Of California | Peptides antimicrobiens et procedes d'utilisation associes |
WO1999002686A1 (fr) * | 1997-07-11 | 1999-01-21 | Boehringer Ingelheim International Gmbh | Genes et polypeptides associes a l'inhibition de la croissance tumorale et a l'apoptose |
WO2000039327A1 (fr) * | 1998-12-23 | 2000-07-06 | Human Genome Sciences, Inc. | Proteines de reconnaissance de peptidoglycane |
-
2000
- 2000-10-20 AU AU15744/01A patent/AU1574401A/en not_active Abandoned
- 2000-10-20 WO PCT/US2000/029177 patent/WO2001029224A2/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997029765A1 (fr) * | 1996-02-16 | 1997-08-21 | The Regents Of The University Of California | Peptides antimicrobiens et procedes d'utilisation associes |
WO1999002686A1 (fr) * | 1997-07-11 | 1999-01-21 | Boehringer Ingelheim International Gmbh | Genes et polypeptides associes a l'inhibition de la croissance tumorale et a l'apoptose |
WO2000039327A1 (fr) * | 1998-12-23 | 2000-07-06 | Human Genome Sciences, Inc. | Proteines de reconnaissance de peptidoglycane |
Non-Patent Citations (1)
Title |
---|
DATABASE EMBL 16 August 2000 (2000-08-16), W. ZHANG ET AL: "Homo sapens hypothetical protein SBBI67 mRNA, complete cds", XP002166773 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8980273B1 (en) | 2014-07-15 | 2015-03-17 | Kymab Limited | Method of treating atopic dermatitis or asthma using antibody to IL4RA |
US8986691B1 (en) | 2014-07-15 | 2015-03-24 | Kymab Limited | Method of treating atopic dermatitis or asthma using antibody to IL4RA |
Also Published As
Publication number | Publication date |
---|---|
WO2001029224A2 (fr) | 2001-04-26 |
AU1574401A (en) | 2001-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001029221A3 (fr) | Nouvelles proteines et polynucleotides codant ces proteines | |
EP1092774A3 (fr) | Antigène de Borrelia burgdorferi OspA, gène le codant et leur utilisations | |
WO2002002621A3 (fr) | Proteines secretees mammaliennes | |
EP1690873A3 (fr) | Composition et procédés de diagnostic de tumeurs | |
CA2343715A1 (fr) | Sequence codante pour un nouveau facteur de differenciation de la croissance d'origine humaine et polypeptide code par cette sequence d'adn, et methode de production correspondante | |
WO2001053312A8 (fr) | Nouveaux acides nucleiques et polypeptides | |
WO2001053455A3 (fr) | Nouveaux acides nucleiques et polypeptides associes | |
WO2000032776A3 (fr) | Polypeptides secretes et transmembranaires et acides nucleiques les codant | |
EP0784059A4 (fr) | Polypeptide antigenique de chlamydia pneumoniae | |
IL98024A0 (en) | Cd44-surface proteins,dna-sequences coding therefor,polypeptides coded by said dna sequences and diagnostic compositions containing the same | |
ATE263836T1 (de) | Chimere proteine, welche borrelia polypeptide beinhalten, verwendungen dafür | |
EP1688430A3 (fr) | Polypeptides sécrétés et transmembranaires ainsi que les acides nucléiques codant pour ceux-ci | |
WO2001029224A3 (fr) | Homologue zgpa1 de peptide de granulocyte | |
EP0907719A4 (fr) | Polypeptides cytokines humains | |
EP0332174A3 (fr) | Agents cellulaires cytotoxiques spécifiques | |
WO2001012665A3 (fr) | Cytokine zalpha48 a enroulement en helice | |
WO2001066748A3 (fr) | Polynucleotides exprimes entiers et polypeptides codes par ces derniers | |
WO2001070986A3 (fr) | Proteine helicoidale zalpha51 | |
WO2002059317A3 (fr) | Proteine contenant le domaine cub zcub3, materiaux et procedes d'obtention | |
AU2676399A (en) | Novel cystine knot protein and materials and methods for making it | |
EP0887410A3 (fr) | ADN codant une protèine activant le plasminogène | |
WO1999031229A3 (fr) | Peptides et acides nucleiques derives d'eisenia foetida et leur utilisation | |
CA2087450A1 (fr) | Somatotropines stables et bioactives modifiees | |
CA2343719A1 (fr) | Nouvelle sequence codant pour le facteur de croissance derive de l'hepatome humain et polypeptide code par cette sequence d'adn, et procede de production de ceux-ci | |
WO2001029223A3 (fr) | Proteine de membrane ztsl1 de type 1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |